Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 56.77% is 11% above its 5-year average of 51.15%, near the high end of its 5-year range (22.35%–68.19%).
1.70% below its 12-month average of 57.75%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 59.80%.
OPERATING MARGIN
56.77%
OPERATING MARGIN AVG TTM
57.75%
OPERATING MARGIN AVG 3Y
52.64%
OPERATING MARGIN AVG 5Y
51.15%
OPERATING MARGIN AVG 10Y
15.53%
OPERATING MARGIN AVG 15Y
-16.39%
OPERATING MARGIN AVG 20Y
-81.15%
CURRENT VS TTM AVG
-1.70%
CURRENT VS 3Y AVG
+7.85%
CURRENT VS 5Y AVG
+10.99%
CURRENT VS 10Y AVG
+265.64%
CURRENT VS 15Y AVG
+446.37%
CURRENT VS 20Y AVG
+169.96%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Halozyme Therapeutics, Inc.
Market Cap
$13.01B
Operating Margin
56.77%
TTM Avg
57.75%
3Y Avg
52.64%
5Y Avg
51.15%
Market Cap
$13.11B
Operating Margin
-113.35%
TTM Avg
-190.29%
3Y Avg
-1892.24%
5Y Avg
-2358.01%
Market Cap
$12.93B
Operating Margin
0.77%
TTM Avg
13.08%
3Y Avg
19.11%
5Y Avg
24.45%
Market Cap
$12.56B
Operating Margin
-19.76%
TTM Avg
-59.77%
3Y Avg
-59.80%
5Y Avg
-72.77%
Market Cap
$12.59B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$12.51B
Operating Margin
3.33%
TTM Avg
2.06%
3Y Avg
2.05%
5Y Avg
2.45%
Market Cap
$12.38B
Operating Margin
10.15%
TTM Avg
12.77%
3Y Avg
11.89%
5Y Avg
11.41%
Market Cap
$12.37B
Operating Margin
18.00%
TTM Avg
16.91%
3Y Avg
21.06%
5Y Avg
16.78%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | $13.01B | 56.77% | 57.75% | 52.64% | 51.15% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.11B | -113.35% | -190.29% | -1892.24% | -2358.01% |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.93B | 0.77% | 13.08% | 19.11% | 24.45% |
| Tempus AI, Inc. (TEM)vs › | $12.56B | -19.76% | -59.77% | -59.80% | -72.77% |
| Baxter International Inc. (BAX)vs › | $12.59B | -2.39% | -1.31% | -6.02% | 0.15% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.51B | 3.33% | 2.06% | 2.05% | 2.45% |
| Penumbra, Inc. (PEN)vs › | $12.48B | 12.45% | 10.35% | 7.09% | 3.40% |
| ICON Public Limited Company (ICLR)vs › | $12.38B | 10.15% | 12.77% | 11.89% | 11.41% |
| Encompass Health Corporation (EHC)vs › | $12.37B | 18.00% | 16.91% | 21.06% | 16.78% |
| Summit Therapeutics Inc. (SMMT)vs › | $13.74B | 0.00% | 0.00% | -2556.35% | -4397.07% |
Gross Margin
78.2%
Operating Margin
56.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 59.80% |
| 2026-03-31 | 48.98% |
| 2025-12-31 | 56.31% |
| 2025-09-30 | 61.51% |
| 2025-06-30 | 62.15% |
| 2025-03-31 | 53.44% |
| 2024-12-31 | 58.89% |
| 2024-09-30 | 56.26% |
| 2024-06-30 | 50.67% |
| 2024-03-31 | 48.78% |
| 2023-12-31 | 43.92% |
| 2023-09-30 | 40.86% |
| 2023-06-30 | 42.73% |
| 2023-03-31 | 33.18% |
| 2022-12-31 | 41.05% |
| 2022-09-30 | 39.86% |
| 2022-06-30 | 22.35% |
| 2022-03-31 | 64.52% |
| 2021-12-31 | 55.42% |
| 2021-09-30 | 65.26% |
| 2021-06-30 | 68.19% |
| 2021-03-31 | 56.99% |
| 2020-12-31 | 63.78% |
| 2020-09-30 | 61.70% |
| 2020-06-30 | 53.52% |
| 2020-03-31 | -12.71% |
| 2019-12-31 | -59.74% |
| 2019-09-30 | -53.08% |
| 2019-06-30 | -35.70% |
| 2019-03-31 | 5.21% |
| 2018-12-31 | -0.12% |
| 2018-09-30 | -99.68% |
| 2018-06-30 | -57.02% |
| 2018-03-31 | -76.81% |
| 2017-12-31 | 66.43% |
| 2017-09-30 | 12.67% |
| 2017-06-30 | -75.49% |
| 2017-03-31 | -93.09% |
| 2016-12-31 | -57.88% |
| 2016-09-30 | -71.40% |
| 2016-06-30 | -65.16% |
| 2016-03-31 | -38.05% |
| 2015-12-31 | 10.46% |
| 2015-09-30 | -111.82% |
| 2015-06-30 | 9.75% |
| 2015-03-31 | -74.53% |
| 2014-12-31 | -12.68% |
| 2014-09-30 | -130.26% |
| 2014-06-30 | -81.26% |
| 2014-03-31 | -210.76% |
| 2013-12-31 | -170.60% |
| 2013-09-30 | -115.49% |
| 2013-06-30 | -153.04% |
| 2013-03-31 | -156.30% |
| 2012-12-31 | -20.22% |
| 2012-09-30 | -375.49% |
| 2012-06-30 | -181.10% |
| 2012-03-31 | -203.50% |
| 2011-12-31 | -764.28% |
| 2011-09-30 | 22.46% |
| 2011-06-30 | 13.35% |
| 2011-03-31 | -128.05% |
| 2010-12-31 | -500.59% |
| 2010-09-30 | -366.07% |
| 2010-06-30 | -378.17% |
| 2010-03-31 | -342.51% |
| 2009-12-31 | -196.72% |
| 2009-09-30 | -460.22% |
| 2009-06-30 | -1197.89% |
| 2009-03-31 | -532.35% |
| 2008-12-31 | -556.04% |
| 2008-09-30 | -454.86% |
| 2008-06-30 | -793.08% |
| 2008-03-31 | -600.02% |
| 2007-12-31 | -742.01% |
| 2007-09-30 | -881.30% |
| 2007-06-30 | -823.23% |
| 2007-03-31 | -503.62% |
| 2006-12-31 | -1095.13% |
| 2006-09-30 | -1055.53% |
| 2006-06-30 | -2853.85% |
| 2006-03-31 | -5012.27% |
| 2005-12-31 | -6406.95% |
| 2005-09-30 | -14684.91% |
| 2005-06-30 | -6445.22% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | -2359.55% |
| 2003-09-30 | -75.06% |
| 2003-06-30 | -60.92% |
| 2003-03-31 | -321.77% |
| 2002-12-31 | -60.76% |
| 2002-09-30 | -75.32% |
